|Podcasts|July 8, 2022

Pharmacy Focus Episode 50: Roe vs Wade and Its Impact on Pharmacy

The best thing for pharmacists to do during this time is provide unbiased, factually accurate information about this topic as a resource.

In this week's episode, we discuss the recent Roe vs Wade reversal and how this decision may impact the pharmacy and its patients in multiple ways with Elizabeth Ruzzo, PhD, founder and CEO of Adyn. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Webinar Registration

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

December 18, 2025 | 1:00 PM ET

Pharmacy Focus Episode 50: Roe vs Wade and Its Impact on Pharmacy

Newsletter

Related Content

SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer

2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer

Advancing Precision Oncology: Pharmacist Perspectives on MRD Testing and Diagnostic Innovation

FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer

Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma

Latest CME

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

New and Approved: FDA’s 2024 Drug Lineup (Pharmacy Technician Credit)

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Navigating the Complexities of Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer in Older Adults: Personalized Treatments for a Vulnerable Population

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights (Pharmacy Technician Credit)

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring (Pharmacy Technician Credit)

Improving the Care of Persons Living With Diabetes Using CGM Devices

The Role of IV Iron in Resolving Iron Deficiency in Heart Failure

From Guidelines to Practice: The Pharmacist’s Role in Chronic Heart Failure Therapy Optimization

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education

Oncology Pharmacists Connect 2026

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

New and Emerging Therapies for the Management of Narcolepsy: A Guide to Patient-Centered Care

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

Shifting Perspectives in Treatment-Resistant Depression: Novel Therapies and Patient-Centered Care

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Expert Insights on the Horizon of HER2-Directed Therapy

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

The Role of the Pharmacist in the Management of Hyperlipidemia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Continuous Glucose Monitoring: What's New in 2025?

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Iron Deficiency Anemia Treatment Considerations in Women’s Health

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Advances in Castration-Sensitive Prostate Cancer: A Pharmacist's Approach to Optimize Novel Antiandrogen Therapies

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes